Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis

British Medical Journal

Volumn 312, Issue 7046, 1996, Pages 1563-1566

  Henry, David ^a,f   Lim, Lynette L Y ^a   Garcia Rodriguez, Luis A ^b   Perez Gutthann, Susanne ^c   Carson, Jeffrey L ^d   Griffin, Marie ^e   Savage, Ruth ^g   Logan, Richard ^h   Moride, Yola ⁱ   Hawkey, Chris ^j   Hill, Suzanne ^k   Fries, James T ^l  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Ciba Geigy SA   (Spain)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f ROYAL NEWCASTLE HOSPITAL   (Australia)

^g CHRISTCHURCH HOSPITAL   (New Zealand)

^h UNIVERSITY OF NOTTINGHAM   (United Kingdom)

ⁱ MCGILL UNIVERSITY   (Canada)

^j QUEEN S MEDICAL CENTRE   (United Kingdom)

^k Therapeutics Goods Administration   (Australia)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZAPROPAZONE; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SULINDAC; TOLMETIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HOSPITAL ADMISSION; HUMAN; META ANALYSIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK;

EID: 8944227048     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7046.1563     Document Type: Article

References (20)

1. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidat anti-inflammatory drugs. Ann Intern Med 1995;123:241-9.
2. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
3. Langman MJS, Weil J, Wainright P, Lawson DH, Rawlins MD, Logan RFA, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-8.
4. Bateman DN. NSAIDs: time to re-evaluate gut toxicity. Lancet 1994;343:1051-2.
5. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991;115:787-96.
6. Bollini P, Garcia-Rodriguez IA, Perez Gutthann S, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease. Arch Intern Med 1992;152:1289-92.
7. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993;105:1078-88.
8. Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;i:462-4
9. Carson JL, Strom BL, Morse ML, West SL, Soper KA, Stolley PD, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987;147:1054-9.
10. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
11. Laporte JR, Carne X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan countries study on upper gastrointestinal bleeding. Lancet 1991;337:85-9.
12. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheum 1993;36:84-90.
13. Nobili A, Mosconi P, Franzosi MG, Tognoni G. Non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding, a post-marketing surveillance case-control study. Pharmacoepidemiology and Drug Safety 1992;1:65-72.
14. Kaufman DW, Kelly JP, Sheehan JE, Laszlo A, Wiholm BE, Alfredsson L, el al. Non-steroidal and-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993;53:485-94.
15. Perez Gutthann S, Garcia Rodriguez LA, Raiford DS. Individual non-steroidal anti-inflammatory drugs and the risk of hospitalisation for upper gastrointestinal bleeding and perforation in Saskatchewan: a nested case-control study. Pharmacoepidemiology and Drug Safety 1994;3(suppl 1):S63.
16. Garcia Rodriguez LA, Walker AM, Perez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992;3:337-42.
17. Abenhaim I., Moride Y. The effect of baseline susceptibility on the relative gastro-toxicity of individual NSAIDs in the elderly: a study with the Quebec database. Post-marketing Surveillance 1993;7:176.
18. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
19. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
20. HRG revisits Feldene. Scrip 1994;13 December:26-7.